Skip to main content
logo
LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4650
0.00 (0.00%)
Last updated: Sep 11, 2026, 11:28 AM AEST

LTR Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
859952109--
Market Cap Growth
-1.67%88.76%-51.74%---
Enterprise Value
657318103--
Last Close Price
0.470.550.290.78--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
116.76136.8534.792219.25--
PB Ratio
4.174.891.6736.98--
P/TBV Ratio
4.174.891.6736.98--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
89.60101.2412.212096.41--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.97-0.97-1.01-1.05-0.83-1.08
Net Debt / EBITDA Ratio
1.411.415.210.45--
Net Debt / FCF Ratio
1.811.817.150.611.123.36
Asset Turnover
0.030.030.090.02-0.01
Inventory Turnover
22.8722.87----
Quick Ratio
33.1033.1045.527.8684.374.11
Current Ratio
34.3634.3645.787.8684.374.11
Return on Equity (ROE)
-54.73%-54.73%-32.47%-277.45%-75.74%-118.83%
Return on Assets (ROA)
-32.96%-32.96%-21.45%-158.79%-41.36%-47.61%
Return on Capital Employed (ROCE)
-69.10%-69.10%-19.40%-236.00%-69.30%-57.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-16.76%-14.30%-10.66%-6.40%--
FCF Yield
-12.83%-10.95%-8.48%-4.69%--
Buyback Yield / Dilution
-8.54%-8.54%-19.96%46.34%--